Literature DB >> 18038766

Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress.

Tatsuhiko Adachi1, Hiroshi Nakagawa, Ivy Chung, Yuichiro Hagiya, Kazuyuki Hoshijima, Noriko Noguchi, Macus Tien Kuo, Toshihisa Ishikawa.   

Abstract

Nrf2, an NF-E2-related transcription factor, plays a critical role in transcriptional upregulation of many target genes, including those for metabolizing enzymes and transporters essential for cellular defense in response to oxidative and/or electrophilic stress. In the present study, we have studied the potential involvement of Nrf2 in induction of human ABC transporter genes under oxidative stress. We created a real-time PCR primer set to quantitatively investigate the induction of human ABC transporters by a redox-active compound tert-butylhydroquinone (tBHQ) in HepG2 cells. We found that mRNA levels of ABCC1, ABCC2, ABCC3, and ABCG2 were significantly elevated in dose- and time-dependent manners. Translocation of Nrf2 into the nuclei occurred concomitantly with the induction of ABCC1 and ABCC2 as well as both heavy and light chains of gamma-glutamylcysteine synthetase (gamma-GCSh and gamma-GCSI) during tBHQ treatments. To examine the potential involvement of Nrf2 in upregulation of the ABC transporters, we treated cells with siRNA to knockdown the expression of Nrf2. Under such Nrf2-knockdown conditions, tBHQ-induced mRNA levels of ABCC2 and ABCG2 were significantly suppressed as were mRNA levels of gamma-GCSh and gamma-GCSI. Interestingly, however, the elevated mRNA level of ABCC1 was little affected by Nrf2 siRNA treatment. We also addressed the involvement of Keap1, which is a negative regulator of Nrf2 by retrieving it in the cytoplasm. When HepG2 cells were treated with Keap1-specifc siRNA, a significant increase was observed in mRNA levels of ABCC1, ABCC2, and ABCG2 as well as gamma-GCSI, suggesting that induction of ABCC2 and ABCG2 by tBHQ is mediated by the Nrf2/Keap1 system, whereas the induction of ABCC1 may involve a Keap1-dependent but Nrf2-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038766

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  31 in total

1.  Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Authors:  Heather M Brechbuhl; Neal Gould; Remy Kachadourian; Wayne R Riekhof; Dennis R Voelker; Brian J Day
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

2.  Isothermal single nucleotide polymorphism genotyping and direct PCR from whole blood using a novel whole-blood lysis buffer.

Authors:  Sylvia T Victor; Alexander Lezhava; Takefumi Ishidao; Ryuta Endo; Yasumasa Mitani; Yoshihiro Kawaoka; Yoshihide Hayashizaki
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

Review 3.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

4.  Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 gene.

Authors:  Mark J Canet; Matthew D Merrell; Bryan G Harder; Jonathan M Maher; Tongde Wu; Andrew J Lickteig; Jonathan P Jackson; Donna D Zhang; Masayuki Yamamoto; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-10-27       Impact factor: 3.922

5.  Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.

Authors:  Anju Singh; Hailong Wu; Ping Zhang; Christine Happel; Jinfang Ma; Shyam Biswal
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

Review 6.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

7.  Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers.

Authors:  Jamie E Moscovitz; Muna S Nahar; Stuart L Shalat; Angela L Slitt; Dana C Dolinoy; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2016-02-05       Impact factor: 3.922

8.  Nrf2 Ameliorates DDC-Induced Sclerosing Cholangitis and Biliary Fibrosis and Improves the Regenerative Capacity of the Liver.

Authors:  Athanassios Fragoulis; Julia Schenkel; Miriam Herzog; Tim Schellenberg; Holger Jahr; Thomas Pufe; Christian Trautwein; Thomas W Kensler; Konrad L Streetz; Christoph Jan Wruck
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 9.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

10.  Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Authors:  Peng-Cheng Li; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek; Zhijian Duan; Qian-Yu Zhang; Ai-Xi Yu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2017-10-23       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.